No results found for “”
No results found for filter “”
-
Blog articles 03.10.22
Pushing the boundaries of science for the benefit of patients
EFPIA's 2022 Pipeline Report
Read Article -
Blog articles 30.09.22
A fact-based analysis of the TRIPS Waiver extension
A COVID-19 TRIPS waiver extension can harm patients
Read Article -
Statements & press releases 28.09.22
‘TEE’ system will revitalise antibiotic research and save money for Europe, new evidence shows
New and novel antibiotics are urgently needed to help tackle the global health threat of antimicrobial resistance (AMR), as infections become more resistant...
Read Article -
Blog articles 27.09.22
We won’t rest until we improve outcomes for patients with even the most resistant leukaemias
As haematological cancer outcomes and survival rates continue to improve worldwide thanks to earlier diagnosis and advances in treatment options, patients...
Read Article -
Blog articles 23.09.22
A spotlight on solid tumours: exploring the impact of a prostate, bladder or lung cancer diagnosis on...
Dr Cathy Taylor, Vice President EMEA Medical Affairs, Therapy Area Strategy at Janssen discusses how a diagnosis with these solid tumour-type cancers impacts...
Read Article -
Blog articles 21.09.22
Improving Understanding of Epidemiology and Impact of Alzheimer’s Disease (Guest blog)
World Alzheimer's Day
Read Article -
Blog articles 21.09.22
Success of Paediatric Regulation inspires us to go further
Review is an opportunity to embrace ‘child-centred’ approach
Read Article -
Statements & press releases 20.09.22
EFPIA and the EFPIA Oncology Platform Congratulate the European Commission on its proposal for a Council...
The Commission’s proposal is an important step forward to ensure people across Europe benefit from the latest innovation in screening and we believe the...
Read Article -
Blog articles 20.09.22
Diabetes & data: can digitalization unlock better care? (Guest blog)
The proposed European Health Data Space (EHDS) is an opportunity to build registries, support mobility and improve outcomes
Read Article -
Blog articles 14.09.22
The future treatment of patients - Combination Products and Companion Diagnostics (Guest blog)
Regulatory Road to Innovation
Read Article -
Statements & press releases 13.09.22
Pharmaceutical industry launches patient information initiative for displaced Ukrainians
Allowing Ukrainian refugees in Poland to access information on prescription medicines in Ukrainian via an electronic product information leaflet
Read Article -
Blog articles 13.09.22
Dropping the dogma: Europe can support patients and innovation
How to retain a life-science ecosystem as well as help address access issues in partnership with industry and European countries.
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 16.06.22
European Multi-Stakeholder Sounding Board Meeting on “Innovation – The key to sustainable cancer care”...
Join the sounding board to discuss how high-quality care pathways and innovation can alleviate the pressure, improve sustainable patient access to high...
Read Article -
EFPIA News 24.05.22
RETHINKING Alzheimer’s disease project, calling for change in Alzheimer’s care, kicks off!
Now is the time to rethink Alzheimer’s disease to improve Alzheimer’s disease care pathway and the lives of people living with it.
Read Article -
EFPIA News 02.05.22
Roberta Savli appointed as Executive Director of Public Affairs at EFPIA
Roberta will take on the new role with immediate effect.
Read Article -
EFPIA News 28.04.22
EFPIA Recommendations on a Connected Data System in Europe
A connected health data ecosystem has the potential to empower more effective and efficient research and development of new treatments and diagnostics....
Read Article -
EFPIA News 22.04.22
Implementing “Good Lay Summary Practice”
Final report of the GLSP Workshop held on the 14, 15 & 21 February 2022.
Read Article -
EFPIA News 11.04.22
New proposals from the research-based pharmaceutical industry should reduce inequalities in patient access...
Europe's pharmaceutical sector is stepping up measures to help deliver faster, more equitable access to medicines for millions of patients across the EU....
Read Article -
EFPIA News 06.04.22
Shortening the WAIT - Patient Access to Medicines in Europe
Disparities in the time it takes for patients to access new medicines in different EU Member States are increasing.
Read Article -
EFPIA News 10.03.22
Pharmaceutical industry response to the war in Ukraine
Supporting people affected by the war
Read Article -
EFPIA News 27.01.22
Shifting the paradigm for ATMPs
Adapting reimbursement and value frameworks to improve patient access in Europe
Read Article -
EFPIA News 11.01.22
Stronger Intellectual Property Rights in EU Free Trade Agreements can boost GDP, productivity, investments...
Discover a recent ECIPE report, supported by EFPIA among other industry associations.
Read Article -
EFPIA News 06.01.22
EFPIA publishes the Evidence MIX (Measures, Insights and eXamples) Report
Evaluating the EU Regulatory System, Assessing the Environment, Gaining Direct Experimental Insights, and Offering Policy Recommendations from Innovative...
Read Article -
EFPIA News 07.12.21
EFPIA response to EPSCO discussion on Strengthening the European Health Union
EFPIA thanks the Slovenian Presidency for its commitment to advancing the EU healthcare debate, and looks forward to working with all stakeholders under...
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 28.09.22
‘TEE’ system will revitalise antibiotic research and save money for Europe, new evidence shows
New and novel antibiotics are urgently needed to help tackle the global health threat of antimicrobial resistance (AMR), as infections become more resistant...
Read Article -
Statements & press releases 20.09.22
EFPIA and the EFPIA Oncology Platform Congratulate the European Commission on its proposal for a Council...
The Commission’s proposal is an important step forward to ensure people across Europe benefit from the latest innovation in screening and we believe the...
Read Article -
Statements & press releases 13.09.22
Pharmaceutical industry launches patient information initiative for displaced Ukrainians
Allowing Ukrainian refugees in Poland to access information on prescription medicines in Ukrainian via an electronic product information leaflet
Read Article -
Statements & press releases 12.09.22
EFPIA statement on the WHO/Europe Tel Aviv ministerial lunch 12 September 2022
We are looking forward to the continued dialogue and collaboration with WHO/Europe and its Member States and all other stakeholders to achieve our common...
Read Article -
Statements & press releases 05.09.22
Pharmaceutical companies to give evidence on responses to Covid-19
European Parliament Committee to hear how strong collaboration and deep research knowledge enabled a swift response to mitigate the devastating impact...
Read Article -
Statements & press releases 26.07.22
EFPIA statement on the EU-Turkey WTO Case on Pharmaceuticals
We reiterate our position in favour of an open and rules-based trading system which best supports the resilience and efficiency of global pharmaceutical...
Read Article -
Statements & press releases 12.07.22
EFPIA statement on the EU4Health 2023 work program
By funding strategic initiatives with clear EU added value, the EU4Health program can support Member States in transforming their health systems after...
Read Article -
Statements & press releases 24.06.22
EFPIA statement on European Council decision on membership applications from Ukraine and Moldova
Read Article -
Statements & press releases 23.06.22
EFPIA welcomes the launch of the EU NCDs Initiative
The EU NCDs Initiative shows renewed political attention to NCDs and delivers a broad, integrated policy response across the main NCDs.
Read Article -
Statements & press releases 22.06.22
EFPIA statement on the establishment of the HTA Coordination Group
Europe has a unique opportunity to enact real step change in how it can attract and bring innovation to patients
Read Article -
Statements & press releases 17.06.22
EFPIA and Vaccines Europe are deeply disappointed about the decision taken by World Trade Organization...
The decision is a serious retrograde step in our collective ability to tackle the COVID-19 pandemic and future global health threats.
Read Article -
Statements & press releases 15.06.22
EFPIA-EURORDIS Joint statement on Patient Access to Medicines for Rare Diseases
EFPIA and EURORDIS share the goal of faster, more equitable access to medicines for patients living with rare disease across Europe. Both the structured...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 03.10.22
Pushing the boundaries of science for the benefit of patients
EFPIA's 2022 Pipeline Report
Read Article -
Blog articles 30.09.22
A fact-based analysis of the TRIPS Waiver extension
A COVID-19 TRIPS waiver extension can harm patients
Read Article -
Blog articles 27.09.22
We won’t rest until we improve outcomes for patients with even the most resistant leukaemias
As haematological cancer outcomes and survival rates continue to improve worldwide thanks to earlier diagnosis and advances in treatment options, patients...
Read Article -
Blog articles 23.09.22
A spotlight on solid tumours: exploring the impact of a prostate, bladder or lung cancer diagnosis on...
Dr Cathy Taylor, Vice President EMEA Medical Affairs, Therapy Area Strategy at Janssen discusses how a diagnosis with these solid tumour-type cancers impacts...
Read Article -
Blog articles 21.09.22
Improving Understanding of Epidemiology and Impact of Alzheimer’s Disease (Guest blog)
World Alzheimer's Day
Read Article -
Blog articles 21.09.22
Success of Paediatric Regulation inspires us to go further
Review is an opportunity to embrace ‘child-centred’ approach
Read Article -
Blog articles 20.09.22
Diabetes & data: can digitalization unlock better care? (Guest blog)
The proposed European Health Data Space (EHDS) is an opportunity to build registries, support mobility and improve outcomes
Read Article -
Blog articles 14.09.22
The future treatment of patients - Combination Products and Companion Diagnostics (Guest blog)
Regulatory Road to Innovation
Read Article -
Blog articles 13.09.22
Dropping the dogma: Europe can support patients and innovation
How to retain a life-science ecosystem as well as help address access issues in partnership with industry and European countries.
Read Article -
Blog articles 05.09.22
More than medicine
Europe’s pharmaceutical industry improves health, advances science, drives innovation and adds economic value
Read Article -
Blog articles 01.09.22
Where innovation happens, matters
The revision of the Pharmaceutical Legislation will define the future of innovation in Europe. Let’s ensure Europeans can see the results of innovation...
Read Article -
Blog articles 01.08.22
We won't rest until lung cancer patients can achieve the best possible outcomes
The introduction of targeted treatments and immunotherapies – which have rapidly become the standard of care – are contributing to better outcomes. And...
Read Article